Previous 10 | Next 10 |
2023-11-09 08:14:06 ET More on Recursion Pharmaceuticals Recursion Pharmaceuticals: Wet Lab Meets Silicon, A Tale Of Two Bottom Lines Recursion Pharmaceuticals: Leveraging AI To Decode Biology And Discover Novel Therapeutics AI to represent 11% of healthcare budgets ...
SALT LAKE CITY, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced two significant updates with their collaborators NVIDIA and Bayer , and a new collaboration with T...
Entered into a collaboration with Tempus giving Recursion access to over 20 petabytes of multimodal oncology data for the purpose of training causal AI models together with Recursion’s proprietary data and for designing biomarker and patient stratification strategies for clinical programs ...
2023-10-31 09:45:00 ET Discovering new drugs is no easy task, and one young company that aims to help in that process is Recursion Pharmaceuticals (NASDAQ: RXRX) . Though it still hasn't brought a product to market just yet, it's begun to receive some attention already for its innov...
2023-10-19 08:31:42 ET More on PTC, Roche, etc. Recursion Pharmaceuticals: Wet Lab Meets Silicon, A Tale Of Two Bottom Lines Roche: Positive Readouts From Pipeline Roche: 2023 Should Mark The Bottom Roche slips after in-line Q3 sales Roche in pact wit...
2023-10-17 09:53:00 ET There is hardly such a thing as a risk-free investment, no matter where you care to look. However, some investments tend to be more risky than others. And in the equity markets, the biotech sector tends to have more than its fair share. Yet, risky stocks can also ofte...
2023-10-11 10:07:00 ET It has been a tumultuous year for the clinical-stage biotech Recursion Pharmaceuticals (NASDAQ: RXRX) . Earlier this year, the company's shares skyrocketed after it announced a partnership with the tech giant Nvidia , but Recursion has since given up all t...
2023-10-04 09:15:00 ET Artificial intelligence (AI) stocks have been hot buys this year, but not all of them make for good long-term investments. Just about every business is trying to get in on the hype and launching AI-powered products and services, which can make it difficult to determin...
2023-10-02 10:45:00 ET Ark Invest CEO Cathie Wood is the ultimate thematic investor. Her flagship fund, Ark Innovation ETF focuses on disruptive new technologies such as artificial intelligence (AI), autonomous vehicles, genomic medicine, molecular diagnostics, and cutting-edge medical ...
2023-09-30 09:15:00 ET Recursion Pharmaceuticals (NASDAQ: RXRX) is a clinical stage company that mixes healthcare with technology and artificial intelligence (AI). Its drug discovery platform, Recursion OS, is the key to making the company a success. The company uses machine learnin...
News, Short Squeeze, Breakout and More Instantly...
Recursion Pharmaceuticals Inc. Company Name:
RXRX Stock Symbol:
NASDAQ Market:
Recursion Pharmaceuticals Inc. Website:
Salt Lake City, June 26, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“ Recursion ”) (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the pricing of its underwritten public offering of 30,769,...